Rosvin F5 - Rosuvastatin Fenofibrate Tablets, Green | Lipid Reduction, Hdl Increase, Triglyceride Control

In order to fulfill the diverse requirements of our valuable clients, we are involved in exporting, manufacturing and supplying of rosvin F5 in Mumbai, Maharashtra, India. Mixed dyslipidaemia among patients with metabolic syndrome or diabetes mellitus is very common. Diabetic dyslipidaemia is characterized by increased low-density lipoprotein cholesterol (LDL-C), elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C), is associated with an increased risk of coronary artery disease (CAD). Rosuvastatin in Rosvin- F significantly reduces LDL-C & increase HDL. Fenofibrate reduces triglycerides level and increases HDL level. Thus, the combination of rosuvastatin and fenofibrate offers an improved and effective therapeutic option in the management of diabetic dyslipidemia.